Form 4: Co-Diagnostics Director Ted Murphy Acquires 30,000 Shares of Common Stock
SEC Form 4 Filing
Director Ted Murphy acquired 30,000 shares of Co-Diagnostics common stock and disposed of 30,000 restricted stock units on May 23, 2024.
Summary
- On May 23, 2024, Ted Murphy, a director of Co-Diagnostics, Inc., acquired 30,000 shares of common stock.
- The acquisition was made at a price of $0.00 per share.
- The same day, Murphy disposed of 30,000 restricted stock units.
- Following these transactions, Murphy directly owns 127,500 shares of Co-Diagnostics common stock and 200,000 restricted stock units.
- The restricted stock units were granted under the company's 2015 Long Term Incentive Plan and vest in installments.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders, allowing investors to monitor their actions.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| July 7, 2022 | 70,000 restricted stock units awarded, vesting every six months commencing November 23, 2022. |
| November 23, 2022 | Commencement of vesting for restricted stock units awarded on July 7, 2022. |
| January 17, 2023 | 40,000 restricted stock units awarded, vesting every six months commencing May 23, 2023. |
| May 23, 2023 | Commencement of vesting for restricted stock units awarded on January 17, 2023. |
| June 12, 2023 | 70,000 restricted stock units awarded, vesting every six months commencing November 23, 2023. |
| November 23, 2023 | Commencement of vesting for restricted stock units awarded on June 12, 2023. |
| May 23, 2024 | Transaction date: Acquisition of 30,000 shares and disposal of 30,000 restricted stock units. |
| May 28, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.